Trial · NCT01430104
Results by group77
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 77
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Serum Calcium Level Over 11.0 Milligrams Per Deciliter (mg/dL) | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | 16 hours postdose | 0 | 0 | participants |
| Number of Participants With Serum Calcium Level Over 11.0 Milligrams Per Deciliter (mg/dL) | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | 24 hours postdose | 0 | participants | |
| Number of Participants With Serum Calcium Level Over 11.0 Milligrams Per Deciliter (mg/dL) and 13.5 mg/dL, Respectively at Any Time Postbaseline | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Serum Calcium > 11.0 mg/dL | 0 | participants | |
| Number of Participants With Serum Calcium Level Over 11.0 Milligrams Per Deciliter (mg/dL) and 13.5 mg/dL, Respectively at Any Time Postbaseline | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Serum Calcium > 13.5 mg/dL | 0 | participants | |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Baseline: 0 h predose | 9.00 | 90% Confidence Interval 8.92 to 9.07 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Baseline: 2 h postdose | 9.11 | 90% Confidence Interval 9.03 to 9.19 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Baseline: 4 h postdose | 8.98 | 90% Confidence Interval 8.91 to 9.05 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Baseline: 6 h postdose | 8.92 | 90% Confidence Interval 8.86 to 8.98 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Baseline: 16 h postdose | 8.97 | 90% Confidence Interval 8.90 to 9.03 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Baseline: 24 h postdose | 8.74 | 90% Confidence Interval 8.67 to 8.81 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Day 1: 0 h predose | 8.74 | 90% Confidence Interval 8.67 to 8.81 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Day 1: 2 h postdose | 9.17 | 90% Confidence Interval 9.10 to 9.24 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Day 1: 4 h postdose | 9.16 | 90% Confidence Interval 9.09 to 9.24 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Day 1: 6 h postdose | 9.14 | 90% Confidence Interval 9.07 to 9.21 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Day 1: 16 h postdose | 8.85 | 90% Confidence Interval 8.79 to 8.91 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Day 1: 24 h postdose | 8.70 | 90% Confidence Interval 8.64 to 8.77 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Day 7: 0 h predose (n=28) | 9.02 | 90% Confidence Interval 8.95 to 9.09 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Day 7: 2 h postdose (n=28) | 9.41 | 90% Confidence Interval 9.33 to 9.48 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Day 7: 4 h postdose (n=28) | 9.43 | 90% Confidence Interval 9.35 to 9.51 | mg/dL |
| Mean Serum Calcium Levels | 600 mg Aspara-CA + 1 µg Alfarol + 20 µg Teriparatide | Day 7: 6 h postdose (n=28) | 9.36 | 90% Confidence Interval 9.29 to 9.42 | mg/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01430104/results